Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting Disorders

Cited by (329)

Items 101–200 of 329

  1. Does FGF23 toxicity influence the outcome of chronic kidney disease?
    Mohammed Shawkat Razzaque · 2008 · Nephrology Dialysis Transplantation
  2. FGF-23, vitamin D and calcification: the unholy triad
    Mohammed Shawkat Razzaque, René St‐Arnaud, Takashi Taguchi, Beate Lanske · 2005 · Nephrology Dialysis Transplantation
  3. Amelioration of the premature ageing‐like features of Fgf‐23 knockout mice by genetically restoring the systemic actions of FGF‐23
    Stephelynn DeLuca, Despina Sitara, K Kang, Richard Marsell, Kjell‐Åke Jönsson, Takashi Taguchi, Reinhold G. Erben, MS Razzaque, Beate Lanske · 2008 · The Journal of Pathology
  4. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease
    Kazuki Kawakami, Ai Takeshita, Kenryo Furushima, Masayasu Miyajima, Ikuji Hatamura, Makoto Kuro‐o, Yasuhide Furuta, Kazushige Sakaguchi · 2017 · Scientific Reports
  5. Fibroblast growth factor 23 and its role in phosphate homeostasis
    Isolde Ramon, Pierre Kleynen, Jean‐Jacques Body, Rafik Karmali · 2009 · European Journal of Endocrinology
  6. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men
    Richard Marsell, Elin Grundberg, Tijana Krajisnik, Hans Mallmin, Magnus K. Karlsson, Dan Mellström, ERIC S. ORWOLL, Claes Ohlsson, Kenneth B. Jonsson, Östen Ljunggren et al. · 2008 · European Journal of Endocrinology
  7. Recent findings in phosphate homeostasis
    Dominique Prié, Laurent Beck, Pablo Ureña, Gérard Friedlander · 2005 · Current Opinion in Nephrology & Hypertension
  8. Antibody-Mediated Activation of FGFR1 Induces FGF23 Production and Hypophosphatemia
    Ai-Luen Wu, Bo Feng, Mark Z. Chen, Ganesh A. Kolumam, Jose Zavala‐Solorio, Shelby K. Wyatt, Vineela D. Gandham, Richard A.D. Carano, Junichiro Sonoda · 2013 · PLoS ONE
  9. PTH and Vitamin D
    Syed Jalal Khundmiri, Rebecca D. Murray, Eleanor DeLand Lederer · 2016 · Comprehensive physiology
  10. Can features of phosphate toxicity appear in normophosphatemia?
    Satoko Osuka, Mohammed Shawkat Razzaque · 2012 · Journal of Bone and Mineral Metabolism
  11. Shedding of klotho by ADAMs in the kidney
    Ellen P. M. van Loon, Wilco P. C. Pulskens, Eline A.E. van der Hagen, Marla Lavrijsen, Marc G. Vervloet, Harry van Goor, René J.M. Bindels, Joost G.J. Hoenderop · 2015 · American Journal of Physiology-Renal Physiology
  12. CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders
    Xiuying Bai, Dengshun Miao, Sophia Xiao, Dinghong Qiu, René St‐Arnaud, Martin P. Petkovich, Ajay Gupta, David Goltzman, Andrew C. Karaplis · 2016 · Journal of Clinical Investigation
  13. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy
    Young Hee Lim, Diana Ovejero, Kristina M. Derrick, Michael Terrence Collins, Keith Adam Choate · 2016 · Journal of the American Academy of Dermatology
  14. Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype
    Baozhi Yuan, Jian Q. Feng, Stephen Bowman, Ying Liu, Robert Daniel Blank, Iris Lindberg, Marc K. Drezner · 2012 · Journal of Bone and Mineral Research
  15. Biological activity of FGF-23 fragments
    Theresa J. Berndt, Theodore A. Craig, Daniel McCormick, Beate Lanske, Despina Sitara, Mohammed Shawkat Razzaque, Marlon Pragnell, Ann E. Bowe, Stephen P. O’Brien, Susan C. Schiavi et al. · 2007 · Pflügers Archiv - European Journal of Physiology
  16. Overexpression of Human PHEX Under the Human β-Actin Promoter Does Not Fully Rescue the Hyp Mouse Phenotype
    Reinhold G. Erben, Dagmar Mayer, Karin Weber, Kenneth B. Jonsson, Harald Jüppner, Beate Lanske · 2005 · Journal of Bone and Mineral Research
  17. Mineralizing Enthesopathy Is a Common Feature of Renal Phosphate-Wasting Disorders Attributed to FGF23 and Is Exacerbated by Standard Therapy in Hyp Mice
    Andrew C. Karaplis, Xiuying Bai, Jean-Pierre René Falet, Carolyn M. Macica · 2012 · Endocrinology
  18. FGF23 Suppresses Chondrocyte Proliferation in the Presence of Soluble α-Klotho both in Vitro and in Vivo
    Masanobu Kawai, Saori Kinoshita, Akihito Kimoto, Yasuhiro Hasegawa, Kazuaki Miyagawa, Miwa Yamazaki, Yasuhisa Ohata, Keiichi Ozono, Toshimi Michigami · 2012 · Journal of Biological Chemistry
  19. The discovery of α-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis
    Y. Nabeshima · 2008 · Cellular and Molecular Life Sciences
  20. Significance of the anti-aging protein Klotho
    Miribane Dërmaku‐Sopjani, Selim Kolgeci, Sokol Abazi, Mentor Sopjani · 2013 · Molecular Membrane Biology
  21. Genetic diseases of renal phosphate handling
    Carsten Alexander Wagner, Isabel Rubio‐Aliaga, Jürg Biber, Nati Hernando · 2014 · Nephrology Dialysis Transplantation
  22. Studies of the DMP1 57-kDa Functional Domain both in vivo and in vitro
    Yongbo Lu, Chunlin Qin, Yixia Xie, Lynda Faye Bonewald, Jian Q. Feng · 2008 · Cells Tissues Organs
  23. Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
    José Manuel Valdivielso, Olga C. Balafa, Robert Ekart, Charles Joseph Ferro, Francesca Mallamaci, Patrick Barry Mark, Patrick Rossignol, Pantelis A. Sarafidis, Lucia Del Vecchio, Alberto Ortíz · 2021 · Drugs
  24. The Regulation of Renal Phosphate Transport
    Judith Tamara Blaine, Edward J. Weinman, Rochelle Cunningham · 2011 · Advances in Chronic Kidney Disease
  25. Hormone-like fibroblast growth factors and metabolic regulation
    Yun Chau Long, Alexei Kharitonenkov · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  26. NFκB-sensitive Orai1 expression in the regulation of FGF23 release
    Bingbing Zhang, Jing Yan, Anja T. Umbach, Hajar Fakhri, Abul Fajol, Sebastian Schmidt, Madhuri S. Salker, Hong Chen, Dorothea Alexander, Daniela Egli-Spichtig et al. · 2015 · Journal of Molecular Medicine
  27. Mineral metabolism and aging: the fibroblast growth factor 23 enigma
    Beate Lanske, Mohammed Shawkat Razzaque · 2007 · Current Opinion in Nephrology & Hypertension
  28. Functional Diversity of Fibroblast Growth Factors in Bone Formation
    Yuichiro Takei, Tomoko Minamizaki, Yuji Yoshiko · 2015 · International Journal of Endocrinology
  29. The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?
    Tobias E. Larsson · 2010 · Nephrology Dialysis Transplantation
  30. Toward a Better Understanding of Klotho
    Yo‐ichi Nabeshima · 2006 · Science of Aging Knowledge Environment
  31. Role of fibroblast growth factor 23 in health and in chronic kidney disease
    Masafumi Fukagawa, Tomoko Nii‐Kono, Junichiro James Kazama · 2005 · Current Opinion in Nephrology & Hypertension
  32. FGF23 in Skeletal Modeling and Remodeling
    Yongbo Lu, Jian Q. Feng · 2011 · Current Osteoporosis Reports
  33. Structural and Biochemical Properties of Fibroblast Growth Factor 23
    Takeyoshi Yamashita · 2005 · Therapeutic Apheresis and Dialysis
  34. Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23
    Peidang Liu, Ling Chen, Xiuying Bai, Andrew C. Karaplis, Dengshun Miao, Ning Gu · 2011 · Brain Research
  35. Early Lethality in Hyp Mice with Targeted Deletion of Pth Gene
    Xiuying Bai, Dengshun Miao, David Goltzman, Andrew C. Karaplis · 2007 · Endocrinology
  36. Growth hormone and Klotho
    Christoph Schmid, Marian Christoph Neidert, Oliver Tschopp, Lisa Sze, René L. Bernays · 2013 · Journal of Endocrinology
  37. New insights into the role of fibroblast growth factor 23 in chronic kidney disease
    Kentaro Nakai, Hirotaka Komaba, Masafumi Fukagawa · 2010 · Journal of Nephrology
  38. FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function
    Ann M. Laszczyk, Dailey Nettles, Tate A. Pollock, Stephanie N. Fox, Melissa L. Garcia, Jing Wang, L. Darryl Quarles, Gwendalyn D. King · 2019 · eNeuro
  39. Phosphate Toxicity and Vascular Mineralization
    Mohammed Shawkat Razzaque · 2013 · Contributions to nephrology
  40. Osteo‐renal regulation of systemic phosphate metabolism
    Mohammed Shawkat Razzaque · 2011 · IUBMB Life
  41. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype
    Xiuying Bai, Dinghong Qiu, Dengshun Miao, David Goltzman, Andrew C. Karaplis · 2008 · American Journal of Physiology-Endocrinology and Metabolism · Retracted
  42. FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes
    Icela Palma Lara, Monserrat Pérez-Ramírez, Patricia García Alonso-Themann, Ana María Espinosa-García, Ricardo Godínez-Aguilar, José Bonilla‐Delgado, Adolfo López-Ornelas, Georgina Victoria-Acosta, María Guadalupe Olguín‐García, Jose G. Moreno et al. · 2021 · International Journal of Molecular Sciences
  43. Vitamin D action
    David Goltzman · 2010 · Annals of the New York Academy of Sciences
  44. RECENT RESEARCH ON THE GROWTH PLATE: Advances in fibroblast growth factor signaling in growth plate development and disorders
    Yangli Xie, Siru Zhou, Hangang Chen, Xiaolan Du, Lin Chen · 2014 · Journal of Molecular Endocrinology
  45. Evidence for FGF23 Involvement in a Bone-Kidney Axis Regulating Bone Mineralization and Systemic Phosphate and Vitamin D Homeostasis
    Aline Martin, L. Darryl Quarles · 2012 · Advances in experimental medicine and biology
  46. Central role of the proximal tubular αKlotho/FGF receptor complex in FGF23-regulated phosphate and vitamin D metabolism
    Ai Takeshita, Kazuki Kawakami, Kenryo Furushima, Masayasu Miyajima, Kazushige Sakaguchi · 2018 · Scientific Reports
  47. Discovery of .ALPHA.-Klotho unveiled new insights into calcium and phosphate homeostasis
    Yo‐ichi Nabeshima · 2009 · Proceedings of the Japan Academy Series B
  48. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion
    Hillel Galitzer, Iddo Z. Ben‐Dov, Vardit Lavi-Moshayoff, Tally Naveh‐Many, Justin Silver · 2008 · Current Opinion in Nephrology & Hypertension
  49. Insights From Genetic Disorders of Phosphate Homeostasis
    Marta Christov, Harald Jüppner · 2013 · Seminars in Nephrology
  50. Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption
    Kristen Johnson, Kymberly K. Levine, Joseph A. Sergi, Jean E. Chamoun, Rachel Roach, Jacqueline Vekich, Mike Favis, Mark Horn, Xianjun Cao, Brian Miller et al. · 2017 · Journal of Bone and Mineral Research
  51. Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men
    Sherri‐Ann M. Burnett‐Bowie, Natalia Mendoza, Benjamin Z. Leder · 2006 · Bone
  52. Antibody to fibroblast growth factor 23-peptide reduces excreta phosphorus of laying hens
    Zhouzheng Ren, Marziyeh Ebrahimi, Daniel E. Bütz, Jordan M. Sand, Keying Zhang, Mark E. Cook · 2016 · Poultry Science
  53. Effects of Tumor-Induced Osteomalacia on the Bone Mineralization Process
    Kamilla Nawrot-Wawrzyniak, Franz Varga, Alexander Nader, Paul Roschger, S Sieghart, Elisabeth Zwettler, Katharina M. Roetzer, Stephan Lang, Richard Weinkamer, Katharina Klaushofer et al. · 2009 · Calcified Tissue International
  54. The Journey From Vitamin D–Resistant Rickets to the Regulation of Renal Phosphate Transport
    Barton S. Levine, Charles R. Kleeman, Arnold J. Felsenfeld · 2009 · Clinical Journal of the American Society of Nephrology
  55. FGF23 and the Parathyroid
    Justin Silver, Tally Naveh‐Many · 2012 · Advances in experimental medicine and biology
  56. Vitamin D, phosphate, and vasculotoxicity
    Ronald B. Brown, Afrozul Haq, Charles F. Stanford, Mohammed Shawkat Razzaque · 2015 · Canadian Journal of Physiology and Pharmacology
  57. Parenteral iron therapy and phosphorus homeostasis: A review
    Kamyar Kalantar‐Zadeh, Tomas Ganz, Henry Trumbo, Melvin H. Seid, Lawrence T. Goodnough, Michael A. Levine · 2021 · American Journal of Hematology
  58. Fibroblast Growth Factor 23
    Michael Hardcastle, Keren E. Dittmer · 2015 · Veterinary Pathology
  59. A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia
    Zhousheng Xiao, Demian Riccardi, Hector Adam Velazquez, Ai Lin Chin, Charles Ryan Yates, Jesse D. Carrick, Jeremy C. Smith, Jerome Y. Baudry, L. Darryl Quarles · 2016 · Science Signaling
  60. Ensemble docking to difficult targets in early‐stage drug discovery: Methodology and application to fibroblast growth factor 23
    Hector Adam Velazquez, Demian Riccardi, Zhousheng Xiao, L. Darryl Quarles, Charles Ryan Yates, Jerome Y. Baudry, Jeremy C. Smith · 2017 · Chemical Biology & Drug Design
  61. IL-1β Drives Production of FGF-23 at the Onset of Chronic Kidney Disease in Mice
    Quiana McKnight, Sarah Jenkins, Xiuqi Li, Tracy Nelson, Arnaud Marlier, Lloyd G. Cantley, Karin E. Finberg, Jackie A. Fretz · 2020 · Journal of Bone and Mineral Research
  62. The bone and the kidney
    Sandro Mazzaferro, Marzia Pasquali, Giuliana Pirrò, Silverio Rotondi, Lida Tartaglione · 2010 · Archives of Biochemistry and Biophysics
  63. Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
    André Mansinho, Arlindo Rebelo Ferreira, Sandra Casimiro, Irina Alho, Inês Vendrell, Ana Lúcia Costa, Rita Sousa, Catarina Abreu, Catarina Pulido, Daniela Macedo et al. · 2019 · International Journal of Molecular Sciences
  64. Fibroblast Growth Factor 23 and Its Receptors
    Xijie Yu, Kenneth E. White · 2005 · Therapeutic Apheresis and Dialysis
  65. Fibroblast Growth Factor 23 and the Bone-Vascular Axis: Lessons Learned From Animal Studies
    Giacomo Zoppellaro, Elisabetta Faggin, Massimo Puato, Paolo Pauletto, Marcello Rattazzi · 2011 · American Journal of Kidney Diseases
  66. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules
    Noriko Ide, Rui Ye, Marie Courbebaisse, Hannes Olauson, Michael Densmore, Tobias E. Larsson, Jun‐ichi Hanai, Beate Lanske · 2018 · American Journal of Physiology-Renal Physiology
  67. Endocrine Regulation of Extra-skeletal Organs by Bone-derived Secreted Protein and the effect of Mechanical Stimulation
    Yuxiang Du, Lingli Zhang, Zhikun Wang, Xuan Zhao, Jun Zou · 2021 · Frontiers in Cell and Developmental Biology
  68. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients
    Mehmet Nuri Turan, Fatih Kırçelli, Mustafa Yaprak, Ali Rıza Şişman, Özkan Güngör, Selen Bayraktaroğlu, Mehmet Özkahya, Gülay Aşçı, Jürgen Floege, Ercan Ok · 2016 · International Urology and Nephrology
  69. Dynamics of serum phosphorus, calcium, and hormones during egg laying cycle in Hy-Line Brown laying hens
    Zhouzheng Ren, Wenqiang Sun, Yanli Liu, Zhipeng Li, Di Han, Xi Cheng, Jiakun Yan, Xiaojun Yang · 2019 · Poultry Science
  70. Elevated serum FGF23 concentrations in plasma cell dyscrasias
    Inge J. Stewart, Claire Roddie, Anthony James Gill, Adele Clarkson, Michiko Mirams, Luke Anthony Coyle, Christopher Wård, Philip Clifton‐Bligh, Bruce G. Robinson, Rebecca Sara Mason et al. · 2006 · Bone
  71. FGF23 Deficiency Leads to Mixed Hearing Loss and Middle Ear Malformation in Mice
    Andrew C. Lysaght, Quan Yuan, Yi Fan, Neil M. Kalwani, Paul A. Caruso, MaryBeth Cunnane, Beate Lanske, Konstantina M. Stanković · 2014 · PLoS ONE
  72. FGF23 and Fetuin-A Interaction in the Liver and in the Circulation
    Deborah Mattinzoli, Masami Ikehata, Koji Tsugawa, Carlo Alfieri, Paola Dongiovanni, Elena Trombetta, Luca V. C. Valenti, Aldamaria Puliti, Lorenza Lazzari, Piergiorgio Messa · 2018 · International Journal of Biological Sciences
  73. Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients
    Michishige Ozeki, Shu-ichi Fujita, Shun Kizawa, Hideaki Morita, Koichi Sohmiya, Masaaki Hoshiga, Nobukazu Ishizaka · 2014 · BMC Nephrology
  74. Genetic Rescue of Glycosylation-deficient Fgf23 in the Galnt3 Knockout Mouse
    Shoji Ichikawa, Amie K. Gray, Leah R. Padgett, Matthew R. Allen, Erica L. Clinkenbeard, Nicole M. Sarpa, Kenneth E. White, Michael J. Econs · 2014 · Endocrinology
  75. A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: Description of the biochemical response of FGF23 to octreotide therapy and surgery
    Marianne Susan Elston, Inge J. Stewart, Roderick John Clifton-Bligh, John V. Conaglen · 2006 · Bone
  76. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
    Marie‐Hélène Lafage‐Proust · 2010 · Kidney International
  77. FGF23: a key player in mineral and bone disorder in CKD.
    Hirotaka Komaba, Masafumi Fukagawa · 2009 · PubMed
  78. Three Novel Mutations of the PHEX Gene in Three Chinese Families with X-linked Dominant Hypophosphatemic Rickets
    Weibo Xia, Xunwu Meng, Yan Jiang, Mei Li, Xiaoping Xing, Li Pang, Ou Wang, Yu Pei, Liyun Yu, Yue Sun et al. · 2007 · Calcified Tissue International
  79. A Systems Biology Preview of the Relationships Between Mineral and Metabolic Complications in Chronic Kidney Disease
    L. Darryl Quarles · 2013 · Seminars in Nephrology
  80. Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
    Makoto Shimizu, Ryuichiro Sato · 2022 · Cells
  81. Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease
    Peng Hu, Qiang Xuan, Bo Hu, Ling Lu, Jing Wang, Yuan Han Qin · 2012 · International Journal of Biological Sciences
  82. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice
    Karin Hollberg, Richard Marsell, Maria Norgård, Tobias E. Larsson, Kenneth B. Jonsson, Göran N. Andersson · 2008 · Bone
  83. Lithium- Sensitive Store-Operated Ca2+ Entry in the Regulation of FGF23 Release
    Bingbing Zhang, Jing Yan, Sebastian Schmidt, Madhuri S. Salker, Dorothea Alexander, Michael Föller, Florian J.W. Lang · 2015 · Neurosignals
  84. Regulation of Hormone-Sensitive Renal Phosphate Transport
    Jyothsna Gattineni, Peter A. Friedman · 2015 · Vitamins and hormones
  85. Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis
    Ravi Shankar Goutam, Vijay Kumar, Unjoo Lee, Jaebong Kim · 2023 · International Journal of Molecular Sciences
  86. Understanding the Biological Activities of Vitamin D in Type 1 Neurofibromatosis: New Insights into Disease Pathogenesis and Therapeutic Design
    Claudia Riccardi, Lorena Perrone, Filomena Napolitano, Simone Sampaolo, Mariarosa Anna Beatrice Melone · 2020 · Cancers
  87. FGF23 gene variation and its association with phosphate homeostasis and bone mineral density in Finnish children and adolescents
    Minna Pekkinen, Christine M. Laine, Riikka E. Mäkitie, Eira Leinonen, Christel J. E. Lamberg-Allardt, Heli T. Viljakainen, Outi Mäkitie · 2014 · Bone
  88. The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos)
    Hamit Yaşar Elli̇dağ, Necat Yılmaz, Fatma Kurtuluş, Özgür Aydın, Esin Eren, Ayça İnci, Süleyman Dolu, Fatma Demet Arslan, Özlem Giray, Aylin Yaman · 2016 · Annals of Neurosciences
  89. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease
    Jiabao Lin, Luqi Lin, Siyu Chen, Lifang Yu, Songjie Chen, Zhaofei Xia · 2021 · Journal of Veterinary Diagnostic Investigation
  90. Osteoblast-lineage calcium/calmodulin-dependent kinase 2 delta and gamma regulates bone mass and quality
    Jenna M. Leser, Olivia M. Torre, Nicole R. Gould, Qiaoyue Guo, Heather Buck, Joe Kodama, Satoru Otsuru, Joseph P. Stains · 2023 · Proceedings of the National Academy of Sciences
  91. Dietary Phosphate Restriction Normalizes Biochemical and Skeletal Abnormalities in a Murine Model of Tumoral Calcinosis
    Shoji Ichikawa, Anthony M. Austin, Amie K. Gray, Matthew R. Allen, Michael J. Econs · 2011 · Endocrinology
  92. Fibroblast growth factor-23 and Klotho in chronic kidney disease
    Marc G. Vervloet, Tobias E. Larsson · 2011 · Kidney International Supplements
  93. Hyperphosphatemia in Renal Failure
    Eberhard Ritz, Marie‐Luise Gross · 2004 · Blood Purification
  94. A novel Phex mutation in a new mouse model of hypophosphatemic rickets
    Celeste Owen, Frieda Chen, Ann Marie Flenniken, Lucy R. Osborne, Shoji Ichikawa, S. Lee Adamson, Janet Rossant, Jane E. Aubin · 2012 · Journal of Cellular Biochemistry
  95. Regulation of mineral metabolism by lithium
    Hajar Fakhri, Ganesh Pathare, Abul Fajol, Bingbing Zhang, C.–Thomas Bock, Reinhard Kandolf, Erwin D. Schleicher, Jürg Biber, Michael Föller, Undine Emmi Lang et al. · 2013 · Pflügers Archiv - European Journal of Physiology
  96. Mineral Bone Disorders in Chronic Kidney Disease
    Jessica Kendrick, Anna J. Jovanovich, Sharon M. Moe · 2018 · Elsevier eBooks
  97. Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease
    Teppei Sakoh, Masaru Nakayama, Takuya Tsuchihashi, Ryota Yoshitomi, Shigeru Tanaka, Eisuke Katafuchi, Akiko Fukui, Yui Shikuwa, Naohiko Anzai, Takanari Kitazono et al. · 2016 · Metabolism
  98. Novel PHEX Mutation Associated with Hypophosphatemic Rickets
    Katharina M. Roetzer, Franz Varga, Elisabeth Zwettler, Kamilla Nawrot-Wawrzyniak, Joerg Haller, Ernst Forster, Klaus Klaushofer A · 2007 · Nephron Physiology
  99. Rabbit model of primary hyperparathyroidism induced by high-phosphate diet
    R.-J. Bai, Xiaoguang Cheng, Dong Yan, Z.-H. Qian, X.-M. Li, H. Qu, Wei Tian · 2011 · Domestic Animal Endocrinology
  100. Clinical Disorders of Phosphate Homeostasis
    Karen E. Hansen, Marc K. Drezner · 2011 · Elsevier eBooks